Nasal drug delivery offers enormous potential, from fast-acting therapies to innovative nose-to-brain treatments. Yet success hinges on precise deposition within the nasal cavity. Patient variability, formulation properties, and spray performance all create challenges. Without the right tools to visualize and measure deposition early, developers face costly inefficiencies, regulatory delays, and lost opportunities to bring breakthrough therapies to patients.
In this webinar, our experts will explore two high-impact areas of intranasal development: formulations designed for rapid systemic absorption and those targeting direct nose-to-brain delivery. We’ll show how differences in spray characterization influence deposition, efficacy, and regulatory acceptance—critical insights for both innovators and generics.
Attendees will see how nasal cast testing provides a clear, visual way to optimize deposition and de-risk formulation design. We’ll share strategies to fine-tune formulations, improve reliability, and accelerate development timelines. The session will deliver actionable insights your team can immediately apply to advance smarter, more effective intranasal products.
If you’re working in nasal formulations or device development, this session is for you. Join us to better understand delivery challenges and discover how nasal cast testing can help design smarter, more effective products. Register today to secure your spot.
Key Learning Objectives
- Design intranasal formulations for fast absorption – Master strategies to enhance rapid and effective API uptake.
- Optimize formulations for nose-to-brain delivery – Learn approaches for targeting deposition to improve efficacy.
- Differentiate spray characterization across formulations – Understand how formulation-dependent spray performance impacts deposition and regulatory outcomes.
- Fine-tune nasal formulations for consistent delivery – Discover tunability pathways that improve precision, reduce risk, and speed development.
